Skip to main content
Fig. 3 | BMC Urology

Fig. 3

From: Short-term prognosis of low-risk prostate cancer patients is favorable despite the presence of pathological prognostic factors: a retrospective study

Fig. 3

Biochemical recurrence-free survival for pathological prognostic factors in low-risk patients. Kaplan–Meier estimates of biochemical recurrence (BCR)-free survival for low-risk patients according to grade group (GG) (a), lymphovascular invasion (LVI) (b), extraprostatic extension (EPE) (c), surgical margins (SM) (d), intraductal carcinoma of the prostate (IDCP) (e), and pathological assessment of the primary tumor (pT) (f)

Back to article page